| Leman SKL SA - Rhinisone 50 μg, suspension pour pulvérisation nasale | | 68335 | | 01 | | Rhinisone 50 μg | | suspension pour pulvérisation nasale | | R01AD09 | | Mometasone | | 09.02.2022 | | |
| | Composition | | mometasoni furoas 0.5 mg ut mometasoni furoas monohydricus, benzalkonii chloridum 0.20 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata q.s. ad solutionem pro 1 g corresp. mometasoni furoas 50 µg pro dosi, doses pro vase 140. | | Packungsbestandteile | | suspension pour pulvérisation nasale | | | | | | Active Agent | Dose |
|---|
| Mometasoni Furoas | 0.5 mg/g |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Aqua Purificata | | | Benzalkonium Chloride | 0.2 mg/g | | Carmellose Sodium | | | Cellulosum Microcristallinum | | | Glycerol | | | Natrii Citras Anhydricus | | | Polysorbatum 80 | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 140 | | | | | No | | 002 | 3 x 140 | | | B | | Yes |
|
|